# AbbVie Inc. (ABBV) — Q2-2013 Earnings Results

**Report date:** 2013-07-26 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q2-2013

## Post-Earnings Brief

### Headline

AbbVie Beats on EPS, Stock Up 1.24%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.82 | N/A | +3.80% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding the company's performance. They emphasized their commitment to innovation and growth.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite the lack of revenue details.

> They highlighted ongoing efforts to strengthen their product pipeline.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

AbbVie's earnings report shows a positive surprise in EPS, which contributed to a 1.24% increase in stock price. The lack of revenue data leaves some uncertainty, but management's focus on product development suggests a strategic approach moving forward. Investors may view the EPS beat as a sign of resilience in the company's financial health.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q2-2013_